Institutional investors purchased a net $3.4 million shares of SRPT during the quarter ended September 2013, and now own 81.47% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
S.A.C. CAPITAL ADVISORS LP Bought 910.2 Thousand shares of Sarepta Therapeutics Inc